Sudden death and the competitive athlete: perspectives on preparticipation screening studies.

Sudden death in healthy athletes is uncommon but, when it occurs, the primary mechanism is cardiovascular. The major cause of sudden death in the young athlete is hypertrophic cardiomyopathy or related conditions characterized by left ventricular hypertrophy, aortic rupture due to cystic medial necrosis and congenital coronary artery abnormalities. In the middle-aged or older athlete, coronary artery disease is the most significant cause of sudden death. Noninvasive screening procedures are currently available that can detect most subjects at risk of sudden death. However, although some potentially lethal diseases can be excluded by a relatively simple screening program, other diseases require expensive procedures, such as echocardiography and exercise electrocardiographic stress testing. This means that the sensitivity of detecting diseases leading to sudden death increases in proportion to the financial resources that can be applied to the screening program. Thus, when a screening program designed to identify all cardiac diseases that have the potential to cause sudden death is planned by a community, school or nonprofessional athletic team, the costs will almost undoubtedly be considered prohibitive. The practicality of applying a community- or school-initiated screening program can be questioned because of the very low incidence of sudden unexpected death in young healthy individuals. It is therefore likely that comprehensive screening programs will be confined to individuals or organizations with adequate financial resources. Less expensive, limited screening can be undertaken by individuals or groups to identify some subjects at risk of sudden death during athletic competition.

[1]  T. D. Sellers,et al.  Ventricular fibrillation in the Wolff-Parkinson-White syndrome. , 1979, The New England journal of medicine.

[2]  M. Ikäheimo,et al.  Noninvasive evaluation of the athletic heart: sprinters versus endurance runners. , 1979, The American journal of cardiology.

[3]  S. Savran,et al.  Prevalence of clinical mitral-valve prolapse in 1169 young women. , 1976, The New England journal of medicine.

[4]  W. Roberts,et al.  Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients. , 1982, Circulation.

[5]  W. Henry,et al.  Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. , 1973, The New England journal of medicine.

[6]  R. Jeresaty Sudden death in the mitral valve prolapse-click syndrome. , 1976, The American journal of cardiology.

[7]  W. Roberts,et al.  Causes of sudden death in competitive athletes. , 1986, Journal of the American College of Cardiology.

[8]  A. Camm,et al.  Q-T INTERVAL SYNDROMES , 1988, The Lancet.

[9]  S. Epstein,et al.  Value and limitations of the electrocardiographic response to exercise in the assessment of patients with coronary artery disease. Controversies in cardiology--II. , 1978, The American journal of cardiology.

[10]  D. Zipes,et al.  Ventricular Tachycardia and Ventricular Fibrillation in a Young Population , 1979, Circulation.

[11]  B. Londeree,et al.  The noninvasive cardiac evaluation of long-distance runners. , 1978, Chest.

[12]  S. Goldberg,et al.  A Quantitative Echocardiographic Study of Champion Childhood Swimmers , 1977, Circulation.

[13]  S. Hunt,et al.  Mitral Valve Prolapse in One Hundred Presumably Healthy Young Females , 1976, Circulation.

[14]  R. O'rourke,et al.  Noninvasive Evaluation of Ventricular Hypertrophy in Professional Athletes , 1976, Circulation.

[15]  W. Henry,et al.  Comparative left ventricular dimensions in trained athletes. , 1975, Annals of internal medicine.

[16]  P. Thompson,et al.  Death during jogging or running. A study of 18 cases. , 1979, JAMA.

[17]  W C Sealy,et al.  The preexcitation syndromes. , 1978, Progress in cardiovascular diseases.

[18]  A. Malliani,et al.  The long Q-T syndrome. , 1975, American heart journal.

[19]  W. Roberts,et al.  Sudden death while running in conditioned runners aged 40 years or over. , 1980, The American journal of cardiology.

[20]  K. Hossack,et al.  Value of maximal exercise tests in risk assessment of primary coronary heart disease events in healthy men. Five years' experience of the Seattle heart watch study. , 1980, The American journal of cardiology.

[21]  L. Pickle,et al.  Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. , 1984, The American journal of cardiology.

[22]  S. Epstein,et al.  Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease. Role of single or combined use of exercise electrocardiographic testing, radionuclide cineangiography and myocardial perfusion imaging. , 1980, The American journal of cardiology.

[23]  H. Wellens,et al.  Electrophysiological studies in patients with the Wolf-Parkinson-White syndrome. , 1979, Herz.

[24]  R. Rifkin,et al.  Bayesian analysis of electrocardiographic exercise stress testing. , 1977, The New England journal of medicine.

[25]  G. Diamond,et al.  Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. , 1979, The New England journal of medicine.

[26]  B. Maron,et al.  Hypertrophic cardiomyopathy: a discussion of nomenclature. , 1979, The American journal of cardiology.

[27]  J. Gottdiener,et al.  Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. , 1981, The American journal of cardiology.

[28]  L. Hinkle,et al.  The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. , 1969, The American journal of cardiology.

[29]  J. Gottdiener,et al.  Hypertrophic Cardiomyopathy with Unusual Locations of Left Ventricular Hypertrophy Undetectable, by M‐mode Echocardiography: Identification by Wide‐angle Two‐dimensional Echocardiography , 1981, Circulation.

[30]  L. Schamroth,et al.  Ventricular extrasystoles, ventricular tachycardia, and ventricular fibrillation: clinical-electrocardiographic considerations. , 1980, Progress in cardiovascular diseases.

[31]  R. Bonow,et al.  Prevalence and significance of an abnormal S-T segment response to exercise in a young athletic population. , 1983, The American journal of cardiology.

[32]  W. Roberts,et al.  Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation. , 1978, The American journal of cardiology.

[33]  L. Teichholz,et al.  Mitral valve prolapse: a review of associated arrhythmias. , 1977, The American journal of medicine.

[34]  B. Maron,et al.  Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet. , 1980, The American journal of cardiology.

[35]  C. A. Gilbert,et al.  Echocardiographic study of cardiac dimensions and function in the endurance-trained athlete. , 1977, The American journal of cardiology.

[36]  W. Roberts,et al.  "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death. , 1978, The American journal of cardiology.

[37]  W. Henry,et al.  Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. , 1978, Circulation.

[38]  F. Epstein,et al.  Relationship of premature systoles to coronary heart disease and sudden death in the Tecumseh epidemiologic study. , 1969, Annals of internal medicine.

[39]  J. .. Abildskov,et al.  Q-T interval syndromes. , 1974, Progress in cardiovascular diseases.

[40]  W. Roberts,et al.  Asymmetric Septal Hypertrophy , 1974 .

[41]  E. Braunwald,et al.  Idiopathic Hypertrophic Subaortic Stenosis: Clinical Analysis of 126 Patients with Emphasis on the Natural History , 1968, Circulation.

[42]  James Tn QT prolongation and sudden death. , 1969 .

[43]  A. Moss,et al.  Clinical significance of ventricular arrhythmias in patients with and without coronary artery disease. , 1980, Progress in cardiovascular diseases.